ABSTRACT
OBJECTIVE: The DIVA study is aimed at setting up a standardized genotypic tropism-testing on proviral-DNA for the routine clinical diagnostic-laboratory. METHODS: Twelve local centres and 5 reference centres (previously cross-validated) were identified. For inter-center validation-procedure, 60 peripheral-blood mononuclear cells (PBMCs) aliquots from 45 HAART-treated patients were randomly chosen for population V3 sequencing on proviral-DNA at local HIV centre and at reference-laboratory. Viral tropism was predicted by Geno2Pheno algorithm (False Positive Rate [FPR] = 20%) as proposed by the European-Guidelines. Quantification of total HIV-1 DNA was based on a method described by Viard (2004). RESULTS: Quantification of HIV-1 DNA was available for 35/45 (77.8%) samples, and gave a median value of 598 (IQR:252- 1,203) copies/10 PBMCs. A total of 56/60 (93.3%) samples were successfully amplified by both the reference and the local virological centers. The overall concordance of tropism prediction between local and reference centers was 54/56 (96.4%). Results of tropism prediction by local centers were: 33/54 (61.1%) R5 and 21/54 (38.9%) X4/DM. CONCLUSION: There was high concordance in the genotypic tropism prediction based on proviral DNA among different virological centers throughout Italy. Our results are in line with other European studies, and support the use of genotypic tropism testing on proviral DNA in patients with suppressed plasma HIV-1 RNA candidate to CCR5-antagonist treatment.
Subject(s)
Genotype , HIV Infections/virology , HIV-1/genetics , Proviruses , Viral Tropism , Female , Genotyping Techniques/standards , HIV Envelope Protein gp120/genetics , HIV Infections/diagnosis , Humans , Leukocytes, Mononuclear/virology , Male , Reproducibility of Results , Viral LoadABSTRACT
OBJECTIVE: The goal of the OSCAR programme is to evaluate the performances of genotypic HIV-1 tropism testing in clinical practice using the enhanced sensitivity version of Trofile (ESTA) as reference-assay. METHODS: HIV-1 coreceptor-usage was assessed using plasma samples from 406 HIV-1 infected patients by ESTA and by gp120 V3 population-sequencing followed by Geno2pheno (set at a False Positive Rate [FPR] of 10% and 5%). RESULTS: ESTA was successful in 365 (89.9%) samples indicating R5 in 254 (69.6%), and DM/X4 in 111 (30.4% of samples (104 [28.5%] DM and 7 [1.9%] X4). Genotypic-testing successfully assessed viral tropism for all 406 samples, including the 41 with undetermined result by ESTA. Genotypic-tropism testing at a FPR of 5% and 10% was 81.1% and 78.4% concordant with ESTA, respectively. Despite a sensitivity of 48.7% and 55.9% at a FPR of 5% and 10%, respectively, a high concordance (specificity: 95.3% for FPR of 5% and 88.2% for FPR of 10%) between genotypic-tropism testing and ESTA was reached in the detection of R5-tropic viruses. CONCLUSION: Our results are in line with other European studies, and support the routine use of genotypic tropism testing in clinical-settings for monitoring of HIV-1 infected patients candidate to or failing CCR5-antagonists.
Subject(s)
CCR5 Receptor Antagonists , HIV Infections/virology , HIV-1/genetics , Receptors, Virus/genetics , Viral Tropism , Female , Genotype , HIV Envelope Protein gp120/chemistry , HIV Envelope Protein gp120/genetics , HIV Infections/genetics , HIV Infections/metabolism , HIV-1/classification , HIV-1/isolation & purification , HIV-1/physiology , Humans , Male , Protein Structure, Tertiary , Receptors, CCR5/genetics , Receptors, CCR5/metabolismABSTRACT
Factors influencing the susceptibility to mucosal candidiasis in HIV-infected patients are not clearly understood. Since in animal models of candidiasis the T helper (Th)1- or Th2-responses are protective or non-protective, respectively, this study was aimed to evaluate the cytokine profile of T-cell response to Candida albicans in the blood and lesional tissues of human immunodeficiency virus (HIV)-infected individuals, suffering, or not, from pseudomembranous oropharyngeal candidiasis (POPC), of HIV-negative women suffering from recurrent vaginal candidiasis (RVC) and of healthy controls. Peripheral blood mononuclear cells from HIV-infected and RVC patients proliferated to C. albicans antigen more than controls. Upon antigen activation, T cells from HIV-infected patients produced low interferon (IFN)-gamma, while only T cells from patients with POPC displayed high interleukin (IL)-4 and IL-5 production. POPC-positive patients also showed higher serum IgE levels than POPC-negative patients. T-cell clones generated from the oral mucosa of one HIV-infected patient with POPC produced IL-4, but not IFN-gamma (Th2 phenotype), whereas clones obtained from vaginal mucosa from one RVC patient or one healthy donor showed a Th1 profile. These findings, showing a non-protective Th0/Th2 response to C. albicans antigen in the blood and lesional mucosa of HIV-infected patients with POPC, may explain the high susceptibility of candidiasis in these subjects.
Subject(s)
Antigens, Fungal/immunology , Candida albicans/immunology , Candidiasis, Oral/immunology , Cytokines/biosynthesis , HIV Infections/complications , Mouth Mucosa/immunology , T-Lymphocytes/immunology , Adult , Antibodies, Fungal/blood , Blood/immunology , Candidiasis, Oral/microbiology , Candidiasis, Oral/pathology , Candidiasis, Vulvovaginal/immunology , Candidiasis, Vulvovaginal/microbiology , Cell Proliferation , Cells, Cultured , Female , Humans , Immunoglobulin E/blood , Male , Middle Aged , Mouth Mucosa/microbiology , Mouth Mucosa/pathologyABSTRACT
A non-tuberculous mycobacterium was isolated, following a vertebral needle aspiration, from the blood of a patient with severe spondylodiscitis. The strain turned out to be different from any known mycobacterial species and was quite drug-susceptible in vitro. The patient improved markedly following treatment with meropenem, clarithromycin and amikacin.
Subject(s)
Antitubercular Agents/therapeutic use , Discitis/drug therapy , Discitis/microbiology , Mycobacterium/drug effects , Mycobacterium/isolation & purification , Base Sequence , DNA, Ribosomal Spacer/analysis , Genes, rRNA , Humans , Male , Middle Aged , Molecular Sequence Data , Mycobacterium/classification , Mycobacterium/genetics , Mycobacterium Infections/drug therapy , Mycobacterium Infections/microbiology , RNA, Ribosomal, 16S/genetics , RNA, Ribosomal, 23S/genetics , Sequence Analysis, DNA , Treatment OutcomeABSTRACT
The impact of infectious diseases (ID) specialist consultation in the management of many types of bacterial infections has been fully demonstrated but not for bone and joint infections (BJIs). Nineteen ID Italian centres collected of data from June 2009 to May 2012. Italian guidelines (2009) were used to determine the appropriateness of the diagnostic and therapeutic process of BJIs before and after consulting an ID specialist. Data on 311 patients were collected: 111 cases of prosthetic joint infection, 99 osteomyelitis, 64 spondylodiscitis and 37 fixation device infection. A significant increase of microbiological investigations, imaging techniques and blood inflammation markers were noted after consulting the ID specialist. Moreover, inappropriateness of treatment duration, dosage, and number of administrations significantly decreased after consultation. Infectious disease specialist intervention in the management of BJIs significantly increases the appropriateness both in performing instrumental and laboratory analysis, but especially in determining the correct therapy.
Subject(s)
Bacterial Infections/diagnosis , Bone Diseases/diagnosis , Joint Diseases/diagnosis , Referral and Consultation , Adolescent , Adult , Aged , Aged, 80 and over , Anti-Bacterial Agents/therapeutic use , Bacterial Infections/etiology , Bone Diseases/etiology , Bone Diseases/therapy , Communicable Diseases , Female , Humans , Italy , Joint Diseases/etiology , Joint Diseases/therapy , Male , Middle Aged , Orthopedic Procedures , Surveys and Questionnaires , Young AdultABSTRACT
The introduction of highly active antiretroviral therapy in 1995 dramatically decreased AIDS-related events and deaths rates; however, the enthusiasm among the medical and social community was soon limited by the growing incidence of various side-effects that often greatly limited patients' quality of life. The second problem caused by such a complex treatment consisted of sub-optimal adherence, with a consequent higher risk of the development of drug resistance.
Subject(s)
Antiretroviral Therapy, Highly Active/methods , HIV Infections/drug therapy , Adult , Antiretroviral Therapy, Highly Active/adverse effects , CD4 Lymphocyte Count , Chronic Disease , Cohort Studies , Didanosine/administration & dosage , Drug Administration Schedule , Female , HIV Protease Inhibitors/administration & dosage , Humans , Male , Middle Aged , RNA, Viral/analysis , Reverse Transcriptase Inhibitors/administration & dosage , Viral Load , Zidovudine/administration & dosageABSTRACT
From the Italian Antiretroviral Resistance Cohort Analysis database, 1104 patients starting ritonavir-boosted darunavir-containing regimen were included as follows: 118 subsequently failed treatment at a median of 11 months (interquartile range: 5-20); 3 years failure proportion: 24.6%. HIV Drug Resistance Database and ANRS interpretation algorithms were associated with a progressive risk prediction of virological failure at adjusted Cox. In contrast, Rega algorithm allows to identify a higher number of patients at risk of failure, without losing statistical significance. Four mutations (V32I, I50V, L76V, I84V) were predictive of failure, the hazard ratio progressively increased by detecting 1 (hazard ratio: 2.0, 95% confidence interval: 1.3 to 3.0), 2 (3.6, 2.0 to 6.6), or 3 of them (9.7, 2.8 to 33.5).
Subject(s)
Drug Resistance, Multiple, Viral/genetics , HIV Infections/drug therapy , HIV Protease Inhibitors/therapeutic use , HIV-1/drug effects , Mutation , Ritonavir/therapeutic use , Sulfonamides/therapeutic use , Adult , Algorithms , Antiretroviral Therapy, Highly Active , Darunavir , Female , HIV Infections/genetics , Humans , Italy , Male , Middle Aged , Risk Factors , Treatment FailureABSTRACT
BACKGROUND: Acute Hepatitis A Virus (HAV) is reported to be an emergent problem in several developed countries. OBJECTIVES AND STUDY DESIGN: The aim of this study was to analyse the HAV strains circulating among individuals with acute HAV infection, apparently transmitted by different routes, in several districts of Tuscany in central Italy, during the year 2008. RESULTS: An outbreak of acute HAV infection occurred from May to August 2008 in Arezzo; 32 individuals were admitted to the hospital, in 25 of them at least a linkage with an infected food handler and/or household contacts was reported and in 3 homosexuality was a possible risk factor. In Florence, from January 2008 to August 2008, 41 individuals mainly homosexual men were admitted to two hospitals with the diagnosis of acute HAV. The phylogenetic analysis of VP1/2A region of HAV was used to characterize these HAV isolates. All viral sequences were assigned to genotype IA. All clustered in the same branch (bootstrap 82%) of phylogenetic tree, thus indicating the same circulating isolate. Apart of one isolate from France and one from Germany which were similar with the "Tuscany" strain reported here, high heterogeneity with the other European HAV strains reported in the GenBank in the last years, was observed. CONCLUSION: The detection of a unique HAV isolate circulating in different Tuscany districts, suggests sequential transmission of HAV infection in this geographical area through possible links among acute hepatitis cases. The application of safe food handling practices and vaccination of homosexual men may contribute to the prevention of HAV infection.
Subject(s)
Disease Outbreaks , Hepatitis A virus/genetics , Hepatitis A virus/isolation & purification , Hepatitis A/epidemiology , Hepatitis A/virology , Risk Factors , Adolescent , Adult , Aged , Antibodies, Viral/blood , Base Sequence , Child , Demography , Female , Food Handling , Genotype , Hepatitis A/transmission , Hepatitis A virus/classification , Hepatitis A virus/immunology , Homosexuality, Male , Humans , Immunoglobulin M/blood , Italy/epidemiology , Male , Middle Aged , Polymerase Chain Reaction , RNA, Viral/analysisSubject(s)
Bacterial Infections/epidemiology , Tick-Borne Diseases/epidemiology , Tick-Borne Diseases/microbiology , Ticks/microbiology , Animals , Bacterial Infections/transmission , Borrelia Infections/epidemiology , Borrelia Infections/transmission , Ehrlichiosis/epidemiology , Ehrlichiosis/transmission , Humans , Italy/epidemiology , Lyme Disease/epidemiology , Lyme Disease/transmission , Rickettsia Infections/epidemiology , Rickettsia Infections/transmission , Risk Factors , Tularemia/epidemiology , Tularemia/transmissionSubject(s)
Erythema Infectiosum/diagnosis , Fetal Diseases/diagnosis , Parvovirus B19, Human/isolation & purification , Prenatal Diagnosis/methods , Adult , Amniotic Fluid/virology , DNA, Viral/analysis , Early Diagnosis , Erythema Infectiosum/transmission , Erythema Infectiosum/virology , Female , Fetal Death/epidemiology , Fetal Death/virology , Fetal Diseases/virology , Humans , Hydrops Fetalis/epidemiology , Hydrops Fetalis/virology , Infant, Newborn , Infectious Disease Transmission, Vertical , Italy , Male , Parvovirus B19, Human/genetics , Polymerase Chain Reaction , Pregnancy , Pregnancy Complications, Infectious/diagnosis , Pregnancy Complications, Infectious/virology , Pregnancy Outcome , Risk FactorsABSTRACT
Establishment of latently infected cell lines from primary effusion lymphomas (PEL) presently is the most efficient system for the propagation of clinical strains of human herpesvirus 8 (HHV-8) in culture. Here we describe a new approach to culture productively replicating HHV-8 from patient samples. A BJAB-derived B-cell line, BBF, was found to retain HHV-8 longer, to support the latent and lytic replication programs, and to produce transmissible virus. Supernatants from n-butyrate-treated peripheral blood mononuclear cells of 24 HHV-8-seropositive renal transplant recipients were used to infect BBF cells, and replicating virus was detected in cultures from 11 patients. Moreover, BBF cells infected with saliva strains showed a highly productive profile regardless of the initial viral load, which confirms that infectious HHV-8 can be present in saliva and also suggests that saliva strains may exhibit a high tropism for B lymphocytes. In conclusion, we established an in vitro system that efficiently detects HHV-8 in samples with low viral loads and that produces infectious progeny. BBF cells can be used to propagate HHV-8 from different biological samples as well as to clarify important issues related to virus-cell interactions in a context distinct from endothelial and PEL-derived cell lines.
Subject(s)
B-Lymphocytes/virology , Herpesvirus 8, Human/isolation & purification , Herpesvirus 8, Human/physiology , Burkitt Lymphoma , Cell Line, Tumor , Herpesvirus 8, Human/genetics , Herpesvirus 8, Human/pathogenicity , Humans , Saliva/virology , Virus Cultivation , Virus Latency , Virus ReplicationABSTRACT
This nonrandomized study compared the virologic and immunologic responses to potent regimens containing either efavirenz or nevirapine after considering potential systematic differences between patients receiving these drugs. Virologic failure was defined as the first of 2 consecutive measurements of virus load >500 human immunodeficiency virus RNA copies/mL. Of the 694 patients included in the analysis, 460 (66.3%) started nevirapine and 234 (33.7%) started efavirenz. The adjusted relative hazard of virologic failure for patients who started nevirapine, compared with those who started efavirenz, was 2.08 (95% confidence interval, 1.37-3.15; P=.0006). In addition, patients receiving efavirenz tended to recover 5 CD4 cells/microL more per quarter (P=.05). Although comparisons of drug efficacy in nonrandomized studies should be viewed with caution, no results from randomized controlled comparisons of these drugs are thought to be available. The findings of this study are in agreement with those of other observational studies.